Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance Assessment of SARS-CoV-2 Detection Through Analysis of Exhaled Breath Aerosols

NCT04508556 is registered in ClinicalTrials.gov with Owlstone Ltd as lead sponsor.

NCT NCT04508556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04508556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance Assessment of SARS-CoV-2 Detection Through Analysis of Exhaled Breath Aerosols
Lead sponsor
Owlstone Ltd
Phase
Observational
Overall status
Completed
Start date
September 30, 2020
Completion date
December 19, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19